Loma Linda University
Loma Linda, California, 92350, United States
NCT Number: NCT04039425
The purpose of the investigator's graduate student research study is to investigate if there are significant changes in hair mineral levels in cancer patients undergoing chemotherapy.
Looking for future studies?
Notify MeVisit 1 - Before the start of chemotherapy
Visit 2- Approximately 2 months after start of chemotherapy
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Use only head hair. Cut samples of hair from back of head (see illustration). Cut hair as close to the scalp as possible. As each piece of hair is cut from the head, save only 3.7 square inches of hair closest to the scalp. According to the Doctors Data Lab, this amount is about enough hair to fill a tablespoon. Cut off and discard the rest. Place the saved hair on the scale. Keep cutting and adding hair to the scale until it tips. Hair collection will be about the weight of one to two paper clips (about 3800 strands). Remove the hair on the scale and put it in the plastic bag. Label the plastic bag with the patient's unique random identification and the date collected. Put the hair into the plastic bag, seal, and send to The Doctor's Data Lab.
Time frame: change between visit 1(baseline/start of chemotherapy) and visit 2 (about 2 months after visit 1)
Mineral levels such as calcium, magnesium, manganese, lead, iron, copper, cobalt, and chromium will be tested. All mineral levels are in ug/g.
Loma Linda University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02108028
Cancer, Chronic Disease
Orange, California, United States
View Trial DetailsNCT05156931
Cancer, Neoplasms
Clermont-Ferrand, France
View Trial DetailsNCT07073807
Behavior, Behavioral Symptoms
Irvine, California, United States
View Trial DetailsNCT07752667
Behavior, Cancer
Istanbul, Turkey (Türkiye)
View Trial Details